ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
9 announcements with these filters
Procter & Gamble Health informed shareholders about an extended SEBI-mandated special window for re-lodging rejected physical share transfer requests until February 4, 2027.
Procter & Gamble Health shareholders approved the re-appointment of Mr. S. Madhavan as an Independent Director for a five-year term starting November 15, 2026.
Procter & Gamble Health held its 59th Annual General Meeting on September 3, 2026, where shareholders discussed financial results and directorial appointments.
Procter & Gamble Health Limited has filed its Business Responsibility & Sustainability Report for the financial year ended March 31, 2026.
Procter & Gamble Health Ltd has rescheduled its 59th AGM to September 3, 2026. The record date for the final dividend and AGM is August 27, 2026.
Procter & Gamble Health reported a 7% increase in quarterly sales to ₹356 crore. Profit After Tax rose 45% to ₹96 crore, aided by asset sale proceeds.
Procter & Gamble Health Ltd reported revenue from operations of ₹363.7 Cr (+7.4% YoY) and net profit of ₹96.2 Cr (+45.3% YoY) for Q1 FY27.
Procter & Gamble Health Limited declared a final dividend of Rs. 45 per share for the fiscal year 2025-2026. The record date is set for August 27, 2026.
Procter & Gamble Health rescheduled its 59th AGM to September 3, 2026. The record date for final dividend is now August 27, 2026.